Involvement of nitric oxide in the promotion of cell survival by ceramide 1-phosphate  by Gangoiti, Patricia et al.
FEBS Letters 582 (2008) 2263–2269Involvement of nitric oxide in the promotion of cell survival by
ceramide 1-phosphate
Patricia Gangoiti, Maria H. Granado, Lide Arana, Alberto Ouro, Antonio Go´mez-Mun˜oz*
Department of Biochemistry and Molecular Biology, University of the Basque Country, P.O. Box 644, 48080 Bilbao, Spain
Received 21 April 2008; revised 16 May 2008; accepted 17 May 2008
Available online 27 May 2008
Edited by Barry HalliwellAbstract Macrophages play vital roles in inﬂammatory re-
sponses, and their number at sites of inﬂammation is strictly reg-
ulated by cell death and division. Here, we demonstrate that
production of nitric oxide (NO) is a major mechanism whereby
ceramide-1-phosphate (C1P) blocks apoptosis in macrophages.
However, NO failed to stimulate macrophage proliferation.
The prosurvival eﬀect of C1P was blocked by inhibitors of induc-
ible NO synthase. The antiapoptotic eﬀect of C1P was also
blocked by phosphatidylinositol 3-kinase or nuclear factor-kappa
B inhibitors. Moreover, NO reversed the inhibitory eﬀect of C1P
on acid sphingomyelinase, but the prosurvival eﬀect of C1P was
independent of this action.
 2008 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Ceramide-1-phosphate (C1P) is implicated in the regulation
of relevant biological functions including cell proliferation
[1,2], apoptosis [3,4], phagocytosis [5,6], and inﬂammation
[7–9]. Although the existence of C1P and its metabolizing en-
zymes, ceramide kinase and C1P phosphatases, in mammalian
tissues have been known for many years [10–13], current
understanding of the metabolic and signaling pathways that
are aﬀected by this bioactive sphingolipid is incomplete. We
previously showed that synthetic short-chain acetyl- (C2)-
and octanoyl (C8)-C1P [1] stimulated DNA synthesis and cell
division in rat ﬁbroblasts. Also these short-chain C1P pro-
tected the cells against the morphological changes and detach-
ment that occurred in cultured ﬁbroblasts after prolongedAbbreviations: A-SMase, acid sphingomyelinase; BMDM, bone mar-
row-derived macrophages; C1P, ceramide-1-phosphate; C2-, acetyl;
C8-, octanoyl; CAPE, caﬀeic acid phenylethyl ester; DTT, diethyltre-
itol; FBS, fetal bovine serum; M-CSF, macrophage-colony stimulating
factor; MAPK, mitogen-activated protein kinase; ERK, extracellular
regulated kinase; MEK, MAPK/ERK kinase; MTS, [3-(4,5-dimethyl-
thiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tet-
razolium, inner salt]; L-NAME, L-nitroarginine methyl ester; L-NIL,
N-iminoethyl-L-lysine; NO, nitric oxide; NOS, nitric oxide synthase;
PBS, phosphate-buﬀered saline; PI3-K, phosphatidylinositol 3-kinase;
TBS, Tris-buﬀered saline; TLC, thin layer chromatography
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doi:10.1016/j.febslet.2008.05.027deprivation of serum, suggesting a role of C1P in cytoprotec-
tion [14]. The mechanisms by which C1P exerted its biological
eﬀects diﬀered from those of other related metabolites with
mitogenic properties. For example, C1P was unable to stimu-
late Ca2+ mobilization [2,8,15], phospholipase D (PLD) [2], or
expression of the early genes c-fos or c-myc [16,17]. By con-
trast, sphingosine-1-phosphate (S1P) or phosphatidic acid
(PA) were potent stimulators of these eﬀects [14].
Two major ﬁndings related to the pro-survival actions of
C1P have recently been reported by our group. Firstly we dem-
onstrated that natural (long-chain) C1P blocked cell death of
primary bone marrow-derived macrophages (BMDM) incu-
bated under apoptotic conditions. This action of C1P involved
direct inhibition of acid sphingomyelinase (A-SMase), and
blockade of the caspase-9/caspase-3 pathway [4]. Secondly,
we found that C1P activated phosphoinositide 3-kinase (PI3-
K) in apoptotic macrophages, and that PI3-K inhibitors abol-
ished the anti-apoptotic eﬀect of C1P [3]. In addition, C1P is
involved in the control of inﬂammatory responses [9]. Pettus
and co-workers ﬁrst reported that ceramide kinase mediates
cytokine and calcium ionophore-induced arachidonic acid re-
lease and prostanoid synthesis [7], and that C1P is a direct
stimulator of calcium-dependent cytosolic phospholipase A2
(cPLA2) [8]. Also, C1P has been involved in the regulation
of phagocytosis in neutrophils [5,6].
An important metabolite with cell signaling properties is ni-
tric oxide (NO). NO is a gas that has been implicated in the
regulation of a variety of physiological and pathological func-
tions. This small molecule is thought to play a dual role, favor-
ing cell viability or inducing apoptotic death depending on cell
type and the amount of NO produced [18–21]. NO can be gen-
erated by three distinct nitric oxide synthases: neuronal NOS
(nNOS or NOS I), endothelial NOS (eNOS or NOS II), and
inducible NOS (iNOS or NOS III). While nNOS and eNOS
are constitutively expressed, iNOS is an inducible enzyme that
can be stimulated by diﬀerent cytokines or endotoxins. The
signaling pathways through which NO transmits its message
are diverse; a classical mechanism of NO action involves acti-
vation of soluble guanylyl cyclase, which then produces cyclic
GMP. The latter has been described as an important second
messenger responsible for mediating a variety of cellular func-
tions, but its actions are somehow controversial. In particular,
NO has been shown to inhibit muscle cell proliferation and
migration whereas it is a potent stimulator of endothelial cell
growth and can protect these cells from apoptosis (reviewed
by [22]).
In the present work we demonstrate for the ﬁrst time that
C1P upregulates iNOS expression and the release of NO,blished by Elsevier B.V. All rights reserved.
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cell survival.2. Materials and methods
2.1. Materials
RPMI 1640 culture medium, ceramide-1-phosphate (from bovine
brain, containing predominantly stearic and nervonic acids), S-nitro-
so-N-acetylpenicillamine (SNAP), caﬀeic acid phenethyl ester (CAPE),
1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), LY294002, and
L-nitroarginine methyl ester (L-NAME) inhibitors were from Sigma
Aldrich. PD98059 inhibitor was purchased from Calbiochem, and de-
ﬁned fetal bovine serum (FBS) was from Gibco. Promega supplied 3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium, inner salt (MTS) and Griess Reagent System.Fig. 1. Induction of iNOS expression and NO release (measured as
nitrite) by C1P. BMDMs were pre-incubated for 24 h in RPMI 1640
with 10% FBS and 1.5% L-cell conditioned medium. (A) iNOS
expression was determined with a speciﬁc antibody to this enzyme as
described in Section 2. Equal loading of protein was monitored using a
speciﬁc antibody to b-actin. Similar results were obtained in each of
three replicate experiments. (B) Results of scanning densitometry of
the exposed ﬁlms are expressed as arbitrary units of intensity and are
the mean ± S.E.M. of three replicate experiments. (C) BMDMs were
incubated in the presence of C1P for 16 h as indicated in Section 2.
Determination of NO was measured as described in Section 2 using a
colorimetric assay based on the Griess reaction. Results are expressed
as concentration of NO (lM, in the form of nitrite) and show the
mean ± S.E.M. of ﬁve independent experiments performed in duplicate
except for the condition with C1P 30 lM which is the mean ± S.D. of
two independent experiments (*P < 0.05, **P < 0.01).N-iminoethyl-L-lysine (L-NIL) was from Alexis Biochemical.
[Methyl-3H] thymidine and SM (choline[14C]methyl) were from Perkin
Elmer. ‘‘Annexin V-FITC apoptosis detection kit’’ was from BD Bio-
sciences. Antibodies to iNOS and b-actin (H-196) were purchased from
Santa Cruz Biotechnology.Fig. 2. The NO donor SNAP does not promote macrophage prolif-
eration. BMDMs were pre-incubated for 24 h in RPMI 1640 with 10%
FBS and 1.5% L-cell conditioned medium. (A) BMDMs were treated
with SNAP for 16 h at the indicated concentrations. Determination of
NO was achieved as described in Section 2. Results show the
mean ± S.E.M. of three independent experiments performed in dupli-
cate. (B) BMDMs were stimulated with C1P or SNAP at the indicated
concentrations for 24 h. [3H] Thymidine was added for the last 12 h of
incubation, and the incorporation of [3H] into DNA was determined as
described in Section 2. Results are expressed as fold stimulation
relative to the control value and show the mean ± S.E.M. of three
independent experiments performed in triplicate (*P < 0.05). (C)
BMDMs were stimulated with SNAP or C1P at the indicated
concentrations for 24 h. Cell growth was determined by the MTS-
formazan assay. Results are expressed as fold stimulation relative to
the control value, and they are the mean ± S.E.M. of three indepen-
dent experiments performed in triplicate.
Fig. 4. Involvement of iNOS in C1P-induced cell survival. BMDMs
were pre-incubated with vehicle (empty bars), L-NAME (10 mM)
(solid bars) or L-NIL (1 mM) (hatched bars) for 30 min, and then
stimulated with 30 lM C1P for 30 h. Cell viability was assessed using
the MTS-formazan assay. Results are expressed as fold stimulation
relative to the control value at 0 h, and they are the mean ± S.E.M. of
three independent experiments performed in triplicate (*P < 0.05).
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Bone marrow-derived macrophages (BMDM) were isolated from fe-
murs of 6-8-week old female CD-1 mice as described [23]. Cells were
plated for 24 h in RPMI 1640 medium containing 10% FBS and
10% L-cell conditioned medium as the source of macrophage colony
stimulating factor (M-CSF) [24]. The non-adherent cells were removed
and cultured in the above medium until about 80% conﬂuence was
reached (5–7 days), and then used in experiments.
2.3. Delivery of C1P to cells in culture
As in previous studies [2–4], C1P was added dispersed in water to the
cells in culture. Stock solutions were prepared by sonicating C1P
(1 mg) in sterile nanopure water (1 ml) on ice using a probe sonicator,
until a clear dispersion was obtained. Final concentration of stock
solution was approximately 1.47 mM. This procedure is preferable
over solutions using organic solvents so as to avoid any unwanted or
toxic eﬀects of the solvents [13].
2.4. Determination of DNA synthesis
BMDMwere seeded at 500000 cells/well in 12-well plates and grown
as indicated above. The macrophages were preincubated for 24 h in
RPMI with 10% FBS and 1.5% MCSF to induce cell growth arrest
[2] and then incubated in the presence or absence of agonists for
24 h. [3H]Thymidine (0.5 lCi/ml) was added for the last 12 h of incu-
bation. The macrophages were washed twice with phosphate-buﬀered
saline (PBS) and the incorporation of [3H]thymidine into DNA was
measured as described previously [1,2].
2.5. Cell viability and proliferation assay
Macrophages were seeded at 25000 cells/well in 96-well plates and
incubated overnight in RPMI 1640 with 10% FBS and 10% L-cell con-
ditioned medium as the source of M-CSF. The medium was then re-
placed by fresh RPMI 1640 medium with 10% FBS in the presence
or absence of agonists and/or inhibitors as appropriate. Cell growth
was estimated by measuring the rate of reduction of the tetrazolium
dye MTS as described [2,24].
2.6. Quantiﬁcation of apoptosis
Apoptosis of macrophages was measured by using an annexin V-
FITC apoptosis detection kit according to the manufacturers protocol
(BD Biosciences). Samples were analyzed by a ﬂow cytometer with an
air-cooled 488 nm argon-ion laser (FACSCalibur, BD Biosciences) and
CellQuest software (Becton Dickinson).
2.7. Determination of nitric oxide concentration
Quantiﬁcation of NO in the form of nitrite, the stable end product of
NO in solution, was measured using a colorimetric assay based on the
Griess reaction. Cells were cultured for 24 h in RPMI with 10% FBS
and 1.5% M-CSF in 24-well, and then incubated in the presence or ab-Fig. 3. SNAP promotes cell survival. BMDMwere incubated in the absence o
Apoptosis was determined by ﬂow cytometry as indicated in Section 2. Resu
viability was assessed using the MTS-formazan assay. Results are expressed a
mean ± S.E.M. of three independent experiments performed in triplicate (*Psence of agonists for 16 h. Nitrite production was evaluated following
the instructions of manufactures (Griess Reagent System, Promega
Corporation). The standard calibration curve was constructed using
sodium nitrite diluted in culture medium. Optical densities (OD) were
measured at 540 nm using an ELISA plate reader.
2.8. Sphingomyelinase assay
The activity of A-SMase was determined as described by Liu and
Hannun using (choline-[14C]methyl) SM as the substrate [25]. A-SMase
activity was proportional to the amount of protein added to the assay,
and the incubation time was adjusted so that <10% of the substrate
was consumed. The reaction rate was proportional to the time of incu-
bation and to protein concentration up to at least 50 lg of enzyme
preparation for 120 min.
2.9. Western blotting
Macrophages were harvested and lysed in ice-cold homogenization
buﬀer as described [23]. About 20–40 lg of protein from each sample
was loaded and separated by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS–PAGE), using 10% or 15% separating gels.
Proteins were transferred onto nitrocellulose paper and blocked for 1
h with 5% skim milk in Tris-buﬀered saline (TBS) containing 0.01%
NaN3 and 0.1% Tween 20, and then incubated overnight with the pri-
mary antibody in TBS/0.1% Tween 20 at 4 C. After three washes withf M-CSF for 30 h or in the presence of SNAP (10 lM) as indicated. (A)
lts are the mean ± S.E.M. of three independent experiments. (B) Cell
s fold stimulation relative to the control value at 0 h, and they are the
< 0.05).
Fig. 5. C1P is a competitive inhibitor of A-SMase. BMDMs were incubated for 30 h in RPMI 1640 in the absence of L-cell conditioned medium and
cell homogenates were then collected. A-SMase activity was assayed in the presence of diﬀerent concentrations of SM or C1P as indicated. Results
are the mean of three independent experiments performed in duplicate.
Fig. 6. Inhibition of A-SMase activity by the NO donor SNAP. (A) Macrophages were treated for 30 h with vehicle (open bars), or 10 lM ODQ
(solid bars), in the presence or absence of 10 lM SNAP. The results are expressed relative to the control value and are the mean ± S.E.M. of three
independent experiments performed in duplicate. (B) BMDM were treated with vehicle (open bars), or with 10 lMODQ (solid bars), in the presence
or absence of 10 lM SNAP for 30 h. Cell viability was assessed using the MTS-formazan assay. Results are expressed relative to the control value at 0
h, and they are the mean ± S.E.M. of three independent experiments performed in triplicate (*P < 0.05).
Fig. 7. The inhibition of A-SMase activity by C1P is independent of cGMP formation. (A) Macrophages were treated for 30 h with vehicle (open
bars), or 10 lM ODQ (solid bars), in presence or absence of 30 lM C1P. Results are expressed relative to the control value and are the mean ±
S.E.M. of three independent experiments performed in duplicate. (B) BMDM were treated with vehicle (open bars), or 10 lM ODQ (solid bars), in
the presence or absence of 30 lMC1P for 30 h as in panel A. Cell viability was assessed using the MTS-formazan assay. Results are expressed as fold
stimulation relative to the control value at 0 h, and they are the mean ± S.E.M. of three independent experiments performed in triplicate (*P < 0.05).
2266 P. Gangoiti et al. / FEBS Letters 582 (2008) 2263–2269
P. Gangoiti et al. / FEBS Letters 582 (2008) 2263–2269 2267TBS/0.1% Tween 20, membranes were incubated with horseradish per-
oxidase-conjugated secondary antibody at 1:5000 dilution for 1 h.
Thereafter the proteins were visualized by enhanced chemilumines-
cence.
2.10. Statistical analyses
Results are expressed as means ± S.E.M. of three independent exper-
iments performed in triplicate, unless indicated otherwise. Statistical
analyses were performed using ANOVA or Students t-test as appro-
priate, with the level of signiﬁcance set at P < 0.05.Fig. 8. Involvement of PI3-K and NF-jB in the induction of iNOS
expression and NO production by C1P. BMDMs were pre-incubated
for 24 h in RPMI 1640 with 10% FBS and 1.5% L-cell conditioned
medium. (A) BMDMs were pre-incubated with 5 lM LY294002 (solid
bars), or vehicle (empty bars) for 30 min, and then stimulated with
50 lM C1P for 8 h, as indicated. Results are expressed as concentra-
tion of NO (lM, in the form of nitrite) and show the mean ± S.E.M. of
three independent experiments performed in triplicate. (B) BMDMs
were pre-incubated with 5 lM LY294002, or 12.5 lg/ml CAPE for 30
min, and then stimulated with 50 lM C1P for 8 h, as indicated. iNOS
expression was determined as described in Section 2. Similar results
were obtained in each of two replicate experiments. (C) Results of
scanning densitometry of the exposed ﬁlms are expressed as arbitrary
units of intensity and are the mean ± S.D. of two replicate experi-
ments. Vehicle (B) (*P < 0.05).3. Results and discussion
One of the key events in macrophage responses to antiapo-
ptotic or proinﬂammatory stimuli is the expression of iNOS
and the subsequent formation of NO. As mentioned above,
C1P promotes cell proliferation and survival of BMDM [2–
4,16,17], and has proinﬂammatory properties [7,8,26]. There-
fore, we hypothesized that iNOS might play an important role
in mediating at least some of the eﬀects of C1P in macro-
phages. Fig. 1(upper panel) shows that C1P upregulates iNOS
expression in BMDM, with maximal eﬀect at about 8 h of
incubation. Consequently NO generation, which was deter-
mined as production of nitrite (see Section 2), was signiﬁcantly
increased (Fig. 1, lower panel). However, production of NO is
not likely involved in the mitogenic eﬀect of C1P as the NO do-
nor SNAP (up to 50 lM), which elevated NO concentration in
these cells (Fig. 2A), failed to stimulate DNA synthesis (Fig.
2B) or macrophage growth (Fig. 2C). In addition to being
mitogenic, C1P is a potent inhibitor of apoptosis in BMDM
[3,4,17], and NO also has prosurvival properties (reviewed by
[22]). To evaluate whether NO was able to block apoptosis
of BMDM, the cells were incubated for 30 h in the absence
of M-CSF, a condition that renders these cells apoptotic
[4,27,28], but in the presence of the NO donor SNAP. Fig. 3
shows that SNAP, signiﬁcantly inhibits apoptosis (panel A)
and increases cell viability (panel B) in M-CSF-starved
BMDM.
Primary cell cultures are probably the best model to study the
mechanisms involved in cell proliferation and promotion of cell
survival. However, transfection of primary macrophages was
highly ineﬃcient ([29], and our unpublished work). We there-
fore used chemical inhibitors to study the contribution of spe-
ciﬁc eﬀectors to macrophage survival. To examine whether
NO was implicated in the antiapoptotic eﬀect of C1P we used
L-NAME, which inhibits all forms of NOS, and L-NIL, a selec-
tive inhibitor of iNOS. Fig. 4 shows that both of these inhibi-
tors were able to reverse the prosurvival eﬀect of C1P
suggesting that upregulation of iNOS is implicated in the mech-
anism whereby C1P blocks cell death. We previously showed
that one of the mechanisms by which C1P blocks apoptosis oc-
curs through inhibition of A-SMase [4], and it was reported
that NO decreases A-SMase activity [30,31]. In agreement with
these observations we found that SNAP causes a signiﬁcant de-
crease in A-SMase in the macrophages (enzyme activity was
decreased by about 32 ± 6, 1%, mean ± S.E.M. of three inde-
pendent experiments), suggesting a possible involvement of
NO in the inhibitory eﬀect of C1P. However, our previous work
in these same cells suggested that the mechanism by which C1P
inhibits A-SMase is by direct physical interaction with the en-
zyme. In fact, using cell homogenates from BMDM, we have
now observed that C1P binds to this enzyme acting as a com-petitive inhibitor with a Ki = 14.45 ± 1.74 lM (Fig. 5). Hence,
it may be possible that C1P-stimulated NO production might
play a role in the promotion of cell survival through a mecha-
nism that is independent of A-SMase inhibition. A major mech-
anism whereby NO exerts its actions is through stimulation of
guanylyl cyclase (GC), the enzyme that produces cyclic GMP
[30]. Fig. 6A shows that the inhibition of A-SMase activity by
SNAP can be reversed by the GC inhibitor 1H-[1,2,4]Oxadiaz-
olo[4,3-a]quinoxalin-1-one (ODQ). In addition, the prosurvival
eﬀect of SNAP was partially abolished by inhibition of GC
(Fig. 6B). However, ODQ did not reverse the inhibitory eﬀect
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eﬀect of C1P (Fig. 7B). Therefore, these ﬁndings suggest that
production of NO may not be essential for inhibition of A-
SMase by C1P, which is in agreement with our previously re-
ported work [4].
Another mechanism by which C1P promotes macrophage
survival is through activation of the phosphoinosite 3-kinase
(PI3-K)/protein kinase B (PKB)/nuclear factor-kappa B (NF-
jB) pathway, as we previously reported [3]. In this context,
inhibition of A-SMase results in decreased intracellular levels
of ceramides, which are potent inhibitors of PKB (reviewed
in [17]), thereby enhancing the prosurvival eﬀect of C1P. To
examine whether this pathway was implicated in the produc-
tion of NO by C1P we used the selective PI3-K inhibitor
LY294002. Fig. 8(panel A) shows that this inhibitor potently
blocked C1P-stimulated NO production, suggesting a possible
implication of iNOS in the prosurvival eﬀect of C1P. Consis-
tent with this observation, our previous work demonstrated
that activation of PI3-K and subsequent phosphorylation of
PKB is a major mechanism whereby C1P blocks apoptosis in
BMDM [3]. In agreement with Fig. 8(panel A) LY290042
inhibited C1P-upregulated iNOS expression (Fig. 8B). More-
over, we demonstrated that the PI3-K/PKB pathway is impli-
cated in the stimulation of the DNA binding activity of NF-jB
in BMDM [3]. Consistent with this observation, inhibition of
this transcription factor with CAPE abolished C1P-upregu-
lated iNOS expression (Fig. 8B).
It can be concluded that induction of iNOS expression and
the subsequent formation of NO is one of the mechanisms
whereby C1P promotes cell survival in BMDM, and that this
pathway is downstream of PI3-K but independent of A-SMase
inhibition.
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